Values First Advisors’s Insmed INSM Stock Holding History

Values First Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	2,352 +149	+7%	+$18K	0.11%	160
2026 Q1	$360K	Buy	2,203 +146	+7%	+$22.4K	0.19%	123
2025 Q4	$358K	Sell	2,057 -3,409	-62%	-$622K	0.19%	124
2025 Q3	$787K	Sell	5,466 -245	-4%	-$30K	0.42%	67
2025 Q2	$575K	Buy	5,711 +474	+9%	+$36.2K	0.31%	91
2025 Q1	$401K	Buy	5,237 +38	+0.7%	+$2.91K	0.23%	117
2024 Q4	$359K	Buy	5,199 +221	+4%	+$15.9K	0.2%	120
2024 Q3	$363K	Buy	+4,978	New	+$367K	0.2%	113
2023 Q2	–	Sell	-3,320	Closed	-$56.6K	–	243
2023 Q1	$56.6K	Buy	+3,320	New	+$64.5K	0.04%	185

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Values First Advisors's INSM Position: Q2 2026 in Review

Values First Advisors increased its Insmed (INSM) stake by 6.8% in Q2 2026, buying an estimated $18K and bringing the position to 2,352 shares worth $251K. The position accounts for 0.11% of the portfolio, ranked #160.

Values First Advisors first reported a position in INSM in Q1 2023 and has held it in 9 quarters since. The position peaked at $787K in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Values First Advisors held 2,352 shares of Insmed worth $251K as of Q2 2026.
Values First Advisors bought 149 Insmed shares in Q2 2026, an estimated $18K.
Insmed made up 0.11% of Values First Advisors's portfolio in Q2 2026, its #160 holding.
Values First Advisors first reported a position in Insmed in Q1 2023 and has held it in 9 quarters since.
Values First Advisors's Insmed position peaked at $787K in Q3 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Values First Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.